Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Elongation factor 2 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109307 |
CONTENTS